These differences help explain why GLP-1 drugs work best for people whose obesity is rooted in gut hormone dysfunction, while those with brain-based appetite signaling issues may respond better to older medications or drug combinations
Leading Players: Top 5 players in this market include Bachem, PolyPeptide Group, CordenPharma, Lonza, WuXi STA (TIDES) , which collectively held a market share of 80% in 2025
These are often described as either purging or breakouts, but they are not the same
Nevertheless, melanotan II did not disappear
Akita T, Shimamura M, Tezuka A, Takagi M, Yamashita C
The benefits of First Ladys glutathione brightening serum extend beyond mere aesthetics